Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices

About this resource:

Non-Systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: August 2017

This report updates previous Advisory Committee on Immunization Practices’ (ACIP) recommendations for human papillomavirus (HPV) vaccination to include a 2-dose schedule for children and adolescents who start the vaccination series before age 15 years. 

ACIP recommends the following schedule for routine HPV vaccination:

  • For people starting the vaccination series before their 15th birthday: 2 doses of HPV vaccine, given  6 to 12 months apart
  • For people starting the vaccination series after their 15th birthday: 3 doses of HPV vaccine, with the second dose given 1–2 months after the first dose, and the third dose given 6 months after the first dose

ACIP also recommends the 3-dose schedule for immunocompromised people.

Read more about this resource

Objectives related to this resource (2)

Suggested Citation

1.

Meites E, Kempe A, Markowitz LE. (2016). Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices. Retrieved from https://www.cdc.gov/mmwr/volumes/65/wr/mm6549a5.htm.